Skip to main content

Medtronic Value Stock - Dividend - Research Selection

Medtronic

ISIN: IE00BTN1Y115 , WKN: A14M2J

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!

How our site works ...

✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month 
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Medtronic plc manufactures and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company\'s Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; diagnostics and monitoring devices; mechanical circulatory support, TYRX, and AF products; and remote monitoring and patient-centered software. It also provides transcatheter heart valves, percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment offers surgical care, wound closure, electrosurgical, hernia mechanical device, mesh implant, ablation, interventional lung, ventilator, capnography, airway, sensor, monitor, compression, dialysis, enteral feeding, wound care, and medical surgical products; stapling, vessel sealing, fixation, and hardware instruments; and gastrointestinal, temperature management, inhalation therapy, and renal care solutions.

 

The company\'s Restorative Therapies Group segment offers products for spine, bone graft substitutes, biologic products, trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis, as well as products to treat conditions of the ear, nose, and throat; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems; and therapies for vasculature in and around the brain. The company\'s Diabetes Group segment offers insulin pumps and consumables, continuous glucose monitoring systems, and Web-based therapy management software.

 

The company was founded in 1949 and is headquartered in Dublin, Ireland.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Medtronic's High Dividend Yield Gets Little Attention on Wall Street -- Should You Buy the Stock Anyway?

2026-09-27
The medical device giant grew its top line by a double-digit percentage in the first quarter of its fiscal 2027.

Why Is Medtronic (MDT) Expanding In Robotics And AI Healthcare?

2026-09-27
Medtronic (NYSE:MDT) agreed a US$700 million partnership with Cornerstone Robotics to distribute the Sentire surgical system globally. The Cornerstone deal expands Medtronic's presence in surgical robotics beyond its existing platforms into a new multi-country distribution arrangement. Medtronic also partnered with Sonus Microsystems on AI-powered wearable ultrasound technology for maternal health programs in Kenya. There is more to Medtronic than the Cornerstone and Sonus partnerships...

Precision Neuroscience raises $250M for brain-computer interface work

2026-09-25
The Series D round is part of a surge in investment into BCI startups and brings Precision Neuroscience’s total funding to $430 million.

Medtronic PLC's Dividend Analysis

2026-09-25
Medtronic PLC (NYSE:MDT) recently announced a total dividend of $0.72 per share with the ex-dividend date set for 2026-09-25, including $0.72 per share cash dividend payable on 2026-10-16. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Medtronic PLC's dividend performance and assess its sustainability.

Could Medtronic (MDT)’s $700 Million Robotics Bet Unlock its Next Growth Engine?

2026-09-24
On September 1, Medtronic plc (NYSE:MDT) announced a $700 million strategic partnership with Hong Kong-based Cornerstone Robotics, securing rights to distribute Cornerstone’s Sentire surgical system in select market-approved regions outside the U.S. Medtronic will co-distribute Sentire alongside its proprietary Hugo robotic-assisted surgery system across Europe, China, and Singapore. The move allows Medtronic to offer tiered […]

Can This Number Push ISRG Stock Higher?

2026-09-24
Intuitive Surgical (ISRG) shares fell 10.4% in the past year, while the S&P 500 returned 16.5%. Much of the market has focused on moderating U.S. procedure growth. The more telling number is 144 trade-ins in fiscal Q2 2026, up from 83 a year earlier. Most came from customers moving to the new da Vinci 5 robot. Those trade-ins matter most if upgrades continue and each surgery also earns more. Is that number a blip, or are customers still trading up.

Dave Ramsey Says You Need More Than 6% Just to Break Even. Dividend Growth Is One Way to Get There.

2026-09-24
A bond coupon that felt safe a decade ago may be quietly bleeding your retirement dry, and Dave Ramsey's hurdle-rate math explains exactly why. The question is which assets can actually climb that bar year after year.

Smoke Evacuation Systems Market Forecasts Growth from $0.20B (2025) to $0.30B by 2031, Profiling CONMED, Medtronic, Stryker & Becton Dickinson

2026-09-24
The global smoke evacuation systems market is forecast to grow from USD 0.20 billion in 2025 to USD 0.30 billion by 2031, at a 7.5% CAGR. Growth is driven by rising minimally invasive, electrosurgical and laparoscopic procedures, stricter surgical smoke safety guidance, and demand for better operating room air quality. Smoke evacuation pencils and wands lead the product segment, while laparoscopic surgery holds the largest application share. The US is expected to record North America’s fastest g

Medical Robots Market Forecasts Growth from $20.6B (2026) to $41.7B by 2031, Profiling Intuitive Surgical, Stryker, Zimmer Biomet & Medtronic

2026-09-24
The global medical robots market is projected to grow from USD 20.6 billion in 2026 to USD 41.7 billion by 2031, at a 15.1% CAGR. Growth is driven by demand for minimally invasive surgery, healthcare automation, precision procedures, and advances in AI-powered surgical, rehabilitation, radiosurgery, hospital, and pharmacy robots. Robotic systems will hold the largest market share, while surgical robots will lead by type. Ambulatory surgery centers are set for the fastest end-user growth, and Asi

Temperature Management Systems Market Forecasts Growth from $3.56B (2026) to $4.58B by 2031, Profiling 3M, Asahi-Kasei, GE Healthcare, Dragerwerk & Medtronic

2026-09-24
The global temperature management systems market is projected to grow from USD 3.56 billion in 2026 to USD 4.58 billion by 2031, at a 5.2% CAGR. Growth is driven by rising surgical volumes, cardiovascular and neurological disorders, perioperative hypothermia prevention, and targeted temperature management in critical care. Patient warming systems and perioperative care led in 2025, while Asia Pacific is expected to grow fastest. Key players include Solventum, GE HealthCare, Dräger, Ecolab, Medtr